Related Experiment Video
Updated: Aug 9, 2025
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
19.7K
Inflammatory Bowel Diseases and Gut Microbiota.
Yuri Haneishi1, Yuma Furuya1, Mayu Hasegawa1
1Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-shi 183-8509, Tokyo, Japan.
International Journal of Molecular Sciences
|February 25, 2023
Summary
Inflammatory bowel disease (IBD) involves gut microbiota changes. Understanding these microbial shifts is key for developing new treatments for IBD and related autoimmune conditions.
Area of Science:
- Gastroenterology
- Microbiome Research
- Immunology
Background:
- Inflammatory bowel disease (IBD) incidence is rising globally.
- IBD pathogenesis involves genetic, environmental, and immune factors, but causes remain unclear.
- Gut microbiota dysbiosis, including reduced diversity, is implicated in IBD initiation.
Purpose of the Study:
- To review the role of gut microbiota in IBD pathogenesis.
- To explore the potential of microbiota modulation for IBD treatment.
Main Methods:
- Literature review of studies on gut microbiota and IBD.
- Analysis of the impact of microbial dysbiosis on IBD development.
- Examination of therapeutic strategies targeting the gut microbiota.
Main Results:
- Gut microbiota dysbiosis is a significant factor in IBD.
- Specific bacterial genera changes are linked to IBD.
- Modulating gut microbiota shows promise for IBD management.
Conclusions:
- Gut microbiota plays a crucial role in inflammatory bowel disease.
- Targeting the gut microbiota via probiotics, FMT, or metabolites offers a therapeutic avenue.
- Further research into specific microbial species is essential for IBD and autoimmune disease treatment.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
263
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
263
01:17Irritable Bowel Syndrome I: Introduction
344
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
344
01:17Chronic Bowel Disorders: Introduction
512
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
512
01:30Inflammatory Bowel Disease II: Crohn's Disease
331
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
331
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
383
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
383
01:29Inflammatory Bowel Disease IV: Pharmacological Management
169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
169